Retatrutide: how is it different?
Retatrutide vs. Semaglutide vs. Tirzepatide: How Their Chemical Structures Shape Their Effects The world of weight loss medications and metabolic…
Medications
CagriSema: Ozempic Plus? (as of mid 2025)
CagriSema: The Next Generation in Obesity and Diabetes Care The incretin drug revolution is expanding rapidly, with medications like Ozempic®…
GLP-1 Mechanism of Action: How It Works in the Body
If you’ve been hearing about GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), you’re not alone. These incretin-based…
GIP Mechanism of Action: How It Works in Metabolism and Weight Loss
GIP Mechanism of Action Most people have heard of GLP-1 thanks to blockbuster weight loss drugs like semaglutide, but there’s…
Glucagon Receptor Mechanism: How It Regulates Blood Sugar and Metabolism
Glucagon Receptor Mechanism When people talk about blood sugar control, insulin usually gets all the attention. But there’s another key…
G protein–coupled receptor (GPCR) - GIP - GLP1 - GLP1 - Health and Wellness - Medications - Retatrutide - Semaglutide - tirzepatideHow GLP-1 Drugs Are Made: Comparing Semaglutide, Tirzepatide, Retatrutide, and More
🔹 1. Do they have a common backbone? Yes.Most of these drugs are GLP-1 receptor agonists (GLP-1 RAs) — meaning…
-
GLP1s and long term effects – Ozempic’s eye problem
Long-Term Effects of GLP-1 Receptor Agonists Benefits (well supported by evidence) Risks / Considerations (long-term safety) Emerging Evidence: Ozempic (Semaglutide)…
Retatrutide – the triple GLP1/GIP/Gluc that everyone will be talking about in 2027
What Is Retatrutide? Retatrutide (LY‑3437943) is an investigational weight‑loss agent developed by Eli Lilly. It’s a triple‑agonist, simultaneously targeting the…
